To conduct global TMT profiling analysis service
Ended Purchase Order Awarded
- Contract number
- 75N92024P00373
- Awardee
-
Cell Signaling Technology, Inc. UEI DEUMJK7A3NH4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $52,000
Award facts
- Opportunity
-
- TMT PROFILING ANALYSIS - Quantitative proteomic an Solicitation · 75N92024Q1117 · Posted Sep 6, 2024
- Contract value 100% obligated
- $52,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Danvers, MA 01923, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed price purchase order contract was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Cell Signaling Technology, Inc. (CST) to conduct global TMT profiling analysis services. The $52,000 award has a period of performance through September 24, 2025.
The contract is based on a solicitation from the National Heart, Lung and Blood Institute seeking quantitative proteomic analysis of paired FBXW7-mutant and FBXW7-wildtype endometrial cancer cell lines through tandem mass tag (TMT) profiling analysis. This research and development work in the physical, engineering, and life sciences does not have a set-aside designation.
CST is a private, family-owned company that develops and produces antibodies, kits, and reagents used to study cell signaling pathways, with a focus on applied systems biology research related to cancer. They have previously provided proteome analysis, mass spectrometry, and ubiquitin characterization services to the National Institutes of Health and the Department of Veterans Affairs.
Quick answers
Who was awarded contract 75N92024P00373?
75N92024P00373 was awarded to Cell Signaling Technology, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 25, 2024.
How much is contract 75N92024P00373 worth?
The government has obligated $52,000 on 75N92024P00373.
Which agency awarded contract 75N92024P00373?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92024P00373, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92024P00373 competed?
The extent of competition for 75N92024P00373 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award